Blog
CANTAB assessments used in EBBINGHAUS cognitive function trial for Amgen's evolocumab
Cambridge Cognition today reports its involvement in Amgen's EBBINGHAUS study with full results being presented at the American College of Cardiology Annual Scientific Session on 18 March 2017.
Design and rationale of the EBBINGHAUS trial
The Journal Clinical Cardiology has published on the design and rationale of the EBBINGHAUS trial: A phase 3, double-blind, placebo controlled, multicenter study to assess the effect of the human anti-PCSK9 monoclonal antibody evolocumab on cognitive function in patients with clinically evident cardiovascular disease receiving statin background lipid-lowering therapy1.
webinar,
web-based testing,
wearables,
voice recognition,
virtual clinical trials,
tower of london,
technology,
takeda,
swm,
subjective measures,
stigma,
social cognition,
smartphones,
schizophrenia research,
schizophrenia,
research funding,
research,
remote testing,
regulations,
recruitment,
prodromal,
pro-cognitive,
presenteeism,
precision psychiatry,
pre-clinical,
pharmacovigilance,
personalised medicine,
patient-centric,
patient recruitment,
parkinson's disease,
pal,
ots,
occupational health,
objective measures,
normative data,
neurotech,
neuroscience,
near-patient testing,
multiple sclerosis,
ms,
mri and cognitive research,
modelling,
mental wellbeing,
mental health,
mci,
major depression,
ied,
hot cognition,
high frequency,
healthcare,
guide,
grant,
funding,
freezing of gait,
ert,
epidemiology,
emotion recognition,
ecological momentary assessments,
ebt,
ebbinghaus,
early career researchers,
early alzheimer's disease,
drug development,
digital tools,
digital health,
depression,
dementia,
cognitive testing,
cognitive science,
cognitive safety,
cognitive impairment,
cognitive function,
cognitive dysfunction,
cognitive deficits,
cognitive biomarkers,
cognitive assessment,
cognition kit,
cognition,
cns summit,
cloud technology,
clinical trials,
clinical trial,
cias,
cgt,
cantab testimonial,
cantab research grant,
cantab for clinical trials,
cantab,
brain health,
birth cohort,
biomarkers,
awards,
automatic speech recognition,
autism,
attention,
asd,
alzheimer's disease,
affective cognition,
adolescents,
absenteeism,
